CN

AACR 2018 Annual Report: Professor Liu Xiaole of Harvard University talks about the key role of big data mining in tumor immunotherapy

Release date:2019-05-31

We are devoted in cancer immuno-oncology precision medicine development. GV20 Oncotherapy has created new generation of cancer novel drug discovery and development platform which integrates cancer genomics, antibody drug design and biological big data mining. We are utilizing our technological advantages to search novel immuno-oncology targets, screen tumor-specific fully human antibody and identify robust response biomarkers

China
Address:Room 801, 781 Cailun Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China
Email:bd@bioxbh.com
USA
Address:One Broadway, 14th floor, Kendall Square, Cambridge, MA 02142, USA
Email:hr@gv20therapeutics.com